BioAge Labs, Inc. (BIOA) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for BioAge Labs, Inc. (BIOA): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 42/100 — a percentile rank of BioAge Labs, Inc.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $325.4M |
| P / S | 31.4× |
| EV / EBITDA | -2.4× |
| Gross margin | 100.0% |
| Operating margin | -1026.3% |
| Net margin | -912.3% |
| Return on equity | -25.2% |
| ROIC | -35.3% |
| Revenue growth | 168.1% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Independent of the events above — derived from BioAge Labs, Inc.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact